Kevin Michael Mullins, Chief Development Officer at LifeStance Health Group, Inc. (LFST), sold 800 shares at $6.11 ($5K) on 2023-03-14, disclosed to the SEC on 2023-03-15.
Scheduled sale ($5k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LFST | SELL | 2024-03-18 | $564K | — | Filing → |
| LFST | SELL | 2024-03-04 | $1.8M | — | Filing → |
| LFST | SELL | 2023-12-04 | $1.5M | — | Filing → |